- Companies
- QTREX Quantum
QTREX Quantum Valuation Multiples
QTREX Quantum is valued at $58M as of September 2026, a 191.5x revenue multiple. In the last FY QTREX Quantum reported revenue of $289K and EBITDA of ($13M).
QTREX Quantum Overview
About QTREX Quantum
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Founded
2018
HQ
Employees
47
Website
Financials (LTM)
EV
$55M
Valuation Multiples
Start free trialQTREX Quantum Financials
QTREX Quantum reported last 12-month revenue of $289K and negative EBITDA of ($11M).
In the same LTM period, QTREX Quantum generated $2K in gross profit, ($11M) in EBITDA losses, and had net loss of ($13M).
Revenue (LTM)
QTREX Quantum P&L
In the most recent fiscal year, QTREX Quantum reported revenue of $289K and EBITDA of ($13M).
QTREX Quantum is unprofitable as of last fiscal year, with gross margin of 1%, EBITDA margin of (4441%), and net margin of (4574%).
Financial data powered by Morningstar, Inc.
QTREX Quantum Stock Performance
QTREX Quantum has current market cap of $58M, and enterprise value of $55M.
Market Cap Evolution
QTREX Quantum's stock price is $0.87.
QTREX Quantum share price decreased by 31.9% in the last year.
QTREX Quantum has an EPS (earnings per share) of $-0.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55M | $58M | 5.2% | - | - | -31.9% | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQTREX Quantum Valuation Multiples
QTREX Quantum trades at 191.5x EV/Revenue multiple, and (5.2x) EV/EBITDA.
EV / Revenue (LTM)
QTREX Quantum Financial Valuation Multiples
As of September 18, 2026, QTREX Quantum has market cap of $58M and EV of $55M.
QTREX Quantum has a P/E ratio of (4.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified QTREX Quantum Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


QTREX Quantum Margins & Growth Rates
QTREX Quantum grew revenue by 16509% but EBITDA decreased by 154% in the last fiscal year.
In the most recent fiscal year, QTREX Quantum reported gross margin of 1%, EBITDA margin of (4441%), and net margin of (4574%).
QTREX Quantum Margins
QTREX Quantum Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
QTREX Quantum Operational KPIs
QTREX Quantum's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
QTREX Quantum's Rule of 40 is 16523% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
QTREX Quantum's Rule of X is 41287% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
QTREX Quantum Competitors
QTREX Quantum competitors include TELA Bio, Outset Medical, Pangaea Oncology, Theraclion, K Pharma, Bactiguard, Rapid Micro Biosystems, Modulight, FluoGuide and SomnoMed.
Most QTREX Quantum public comparables operate across Medical Devices, HealthTech and DeepTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $80M | ($32M) | 1.1x | 1.1x | (2.6x) | (2.8x) | |||
| $119M | ($70M) | 0.1x | 0.1x | (0.2x) | (0.3x) | |||
| $17M | ($1M) | 3.8x | 3.7x | (58.0x) | (19.8x) | |||
| $1M | ($7M) | 45.3x | - | (9.0x) | - | |||
| - | ($6M) | - | - | (8.7x) | - | |||
| $22M | $4M | 3.1x | 3.0x | 16.3x | 20.9x | |||
| $34M | ($44M) | 1.8x | 1.6x | (1.3x) | (1.4x) | |||
| $8M | ($343K) | 5.9x | 5.7x | (141.1x) | 89.8x | |||
This data is available for Pro users. Sign up to see all QTREX Quantum competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by QTREX Quantum
QTREX Quantum has acquired 1 company to date.
Last acquisition by QTREX Quantum was on April 5th 2026. QTREX Quantum acquired Nano Dimension (AME unit) for $13M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by QTREX Quantum
| Description | Nano Dimension (AME unit) is a multi-material additive manufacturing platform from Israeli 3D printing firm Nano Dimension Ltd. (NASDAQ: NNDM). High-precision inkjet printing produces functional electronics like multi-layer PCBs for aerospace and defense. Printers, inks, and services drive revenue. |
| HQ Country | |
| HQ City | - |
| Deal Date | 5 Apr 2026 |
| Valuation | $13M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all QTREX Quantum acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout QTREX Quantum
| When was QTREX Quantum founded? | QTREX Quantum was founded in 2018. |
| Where is QTREX Quantum headquartered? | QTREX Quantum is headquartered in Israel. |
| How many employees does QTREX Quantum have? | As of today, QTREX Quantum has over 47 employees. |
| Is QTREX Quantum publicly listed? | Yes, QTREX Quantum is a public company listed on Nasdaq. |
| What is the stock symbol of QTREX Quantum? | QTREX Quantum trades under QTEX ticker. |
| When did QTREX Quantum go public? | QTREX Quantum went public in 2021. |
| Who are competitors of QTREX Quantum? | QTREX Quantum main competitors include TELA Bio, Outset Medical, Pangaea Oncology, Theraclion, K Pharma, Bactiguard, Rapid Micro Biosystems, Modulight, FluoGuide, SomnoMed. |
| What is the current market cap of QTREX Quantum? | QTREX Quantum's current market cap is $58M. |
| What is the current revenue of QTREX Quantum? | QTREX Quantum's last 12 months revenue is $289K. |
| What is the current revenue growth of QTREX Quantum? | QTREX Quantum revenue growth (NTM/LTM) is 16509%. |
| What is the current EV/Revenue multiple of QTREX Quantum? | Current revenue multiple of QTREX Quantum is 191.5x. |
| Is QTREX Quantum profitable? | No, QTREX Quantum is not profitable. |
| What is the current EBITDA of QTREX Quantum? | QTREX Quantum has negative EBITDA and is not profitable. |
| What is QTREX Quantum's EBITDA margin? | QTREX Quantum's last 12 months EBITDA margin is (3709%). |
| What is the current EV/EBITDA multiple of QTREX Quantum? | Current EBITDA multiple of QTREX Quantum is (5.2x). |
| How many companies QTREX Quantum has acquired to date? | As of September 2026, QTREX Quantum has acquired 1 company. |
| What was the largest acquisition by QTREX Quantum? | $13M acquisition of Nano Dimension (AME unit) on 5th April 2026 was the largest M&A QTREX Quantum has done to date. |
| What companies QTREX Quantum acquired? | QTREX Quantum acquired Nano Dimension (AME unit). |
| In how many companies QTREX Quantum has invested to date? | QTREX Quantum hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to QTREX Quantum
Lists including QTREX Quantum
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




